Manufacturing

Articles

Contract development and manufacturing organization (CDMO), Yposkesi, has entered into an agreement in principle with Axovant Sciences.

Yposkesi Announces Agreement in Principle with Axovant to Expand Gene Therapy Manufacturing Capacity

GE Healthcare will collaborate with Wego Pharmaceutical in China for local production and supply of GE Healthcare’s Fortem single-use consumables.

GE Healthcare Manufactures Single-Use Consumables in China

The company has rolled out the first batch of TRACON Pharmaceutical’s lead product candidate from its Singapore-based single-use bioreactor.

Lonza Releases First SUB Batch for TRACON Pharmaceuticals

A project funded by BioProNET will investigate optimization for bioprocessing of gene therapy vectors using hydrodynamic fluid flow fields.

Cobra Biologics and the University of Leeds Collaborate on Viral Vector Bioprocessing

Mark Witcher is senior consultant at Brevitas Consulting, witchermf@aol.com

Harry Silver is senior process/facility designer at Harry Silver Designs.

A multi-purpose biopharmaceutical manufacturing facility using a matrix of multi-functional cleanrooms can be adapted to efficiently meet the capacity challenges of both supplying clinical trials and launching products.

Multi-Purpose Biopharmaceutical Manufacturing Facilities Part 1:  Product Pipeline Manufacturing

The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development. 

Swedish Government and GE Healthcare Open an Innovation Center for Life Sciences

Drug product approval from FDA follows previous approvals from European and Japanese authorities.

FDA Approves Drug Product Manufacturing for Samsung BioLogics

Increasing dwell time can improve tablet production.

The Case for Extended Dwell Flat Tooling

The acquisition will place Cambrex into the finished dosage form CDMO market.

Cambrex to Acquire Halo Pharma for $425 Million

The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.

Manufacturing Services